Copper and Zinc levels in normal and malignant tissues
- 1 September 1983
Abstract
The copper and zinc levels in 53 malignant and 47 normal human tissue samples were measured. In the malignant tissues, the mean copper concentration was 46% higher (P < 0.001) than in the normal ones. Analysis of the individual organs showed this increment to be statistically significant in malignancies of the large bowel, stomach, urinary bladder and female reproductive organs, while in cancer of the breast, kidney and testis, the increase in copper level was not significant. The mean zinc concentration in the malignant tissues was not significantly different from that in the corresponding normal tissue specimens (‐11%; P < 0.2). In breast cancer, however, tissue zinc levels were increased by 72% (P < 0.01), and decreased markedly in carcinoma of the kidney (‐73%). A hypothesis for the possible mechanism involving elevated tissue copper levels in biological damage (previously caused by free radicals) which may be responsible for the malignant process, is presented and discussed.This publication has 24 references indexed in Scilit:
- Iron, copper, and zinc liver tissue levels in patients with malignant lymphomasCancer, 1980
- Serum copper and zinc measurements in patients with osteogenic sarcomaCancer, 1978
- Copper and zinc levels in serum from human patients with sarcomasCancer, 1976
- Serum copper observations in patients with malignant lymphomaCancer, 1973
- Significance of serum copper levels in adult patients with Hodgkin's diseaseCancer, 1973
- Copper and Zinc Concentration in the Plasma of Leukaemic ChildrenBritish Journal of Haematology, 1973
- Serum copper in Hodgkin's disease in childrenCancer, 1973
- Value of serum copper measurement in lymphomas and several other malignanciesCancer, 1972
- SERUM COPPER AND MAGNESIUM LEVELS IN LEUKÆMIA AND MALIGNANT LYMPHOMAThe Lancet, 1971
- Prolonged observations on variations in the serum copper in Hodgkin's diseaseClinical Radiology, 1969